April 2, 2019
The Japan unit of GlaxoSmithKline said on April 1 that it and Daiichi Sankyo dissolved their vaccine joint venture arrangement the same day, transferring assets and operations at their JV, Japan Vaccine, back to respective companies. The two drug makers...read more